More than 39 million people in the United States experience migraine, according to the American Migraine Foundation. For some, the condition is an infrequent one, but for millions of others, it may be disabling, occurring so frequently and with such ferocity that nearly every aspect of their lives is affected.

Elizabeth Briand

In February 2024, FDA approved Exblifep (cefepime hydrochloride/enmetazobactam—Allecra Therapeutics), a new antibiotic that is indicated for complicated UTIs, including pyelonephritis, in individuals 18 years and older.

Lauren Howell, PharmD

Recent buzz around a veterinary medicine company developing drugs to extend the lifespan in dogs by targeting the underlying causes of aging has some wondering, if it works for dogs, will it work for humans? The promise of eternal youth has renewed interest in oxidized nicotinamide adenine dinucleotide (NAD+) supplementation.

Mickie Cathers

When allergies cause congestion, itchy and runny nose, sneezing, and watery eyes, most patients reach for antihistamines and decongestants. While both are available as tablets and capsules, nasal sprays are also readily accessible and often work much faster than pills. Several types of nonprescription decongestant, antihistamine, and corticosteroid sprays are convenient and suitable for allergy relief.

Mary Warner

Updates from FDA